Last reviewed · How we verify
NCT06903390
Investigation of the Effect of Information on the Empowerment of Cancer Patients Using Question Prompt List: A Mixed Method Study
NA trial testing QPL-based Communication Intervention in Neoplasms (Cancer / Tumors) in 96 participants. Completed in 1 March 2025.
1 March 2025
Quick facts
| Lead sponsor | Marmara University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | health services research |
| Enrollment | 96 |
| Start date | 1 March 2024 |
| Primary completion | 1 March 2025 |
| Estimated completion | 1 March 2025 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- QPL-based Communication Intervention
Conditions studied
- Neoplasms (Cancer / Tumors) — all drugs for Neoplasms (Cancer / Tumors) →
- Patient Participation — all drugs for Patient Participation →
- Patient-Centered Care — all drugs for Patient-Centered Care →
- Health Communication — all drugs for Health Communication →
Sponsor
Marmara University
Who can join
18 and older, any sex, with Neoplasms (Cancer / Tumors) or Patient Participation. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Brief Summary The goal of this study is to understand how patient empowerment and a Question Prompt List (QPL) can help cancer patients. The main questions this study aims to answer are: What are the views of nurses, physicians, and cancer patients on patient empowerment? Does using a Question Prompt List (QPL) improve patient empowerment and reduce anxiety? Researchers will collect qualitative and quantitative data by measuring patient empowerment and anxiety levels. Who can participate? Cancer patients receiving treatment at Private Anadolu Medical Center Hospital Nurses and physicians working with cancer patients What will participants do? Answer survey questions about their experiences with empowerment, anxiety, and communication Participate in interviews to share their thoughts on patient empowerment Use a Question Prompt List (QPL) during medical consultations Why is this study important? Many cancer patients struggle with anxiety and lack of information about their care. A Question Prompt List (QPL) may help patients ask better questions, feel more in control of their treatment, and reduce anxiety. This study will contribute to oncology research and help develop a culture-specific QPL for use in cancer care. This study will take place at Private Anadolu Medical Center Hospital from January 2023 to November 2024.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06903390
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Marmara University trials
Trials by the same sponsor.
- NCT07533734 — The Effects of an Augmented Reality-Based Mirror Therapy System in Patients With Stroke · NA · not yet recruiting
- NCT07474181 — Simulation-Based Training for Urinary Catheterization Skills in Nursing Students · NA · not yet recruiting
- NCT07486349 — Shoulder Pericapsular Block Versus Interscalene Block in Arthroscopic Shoulder Surgery · NA · not yet recruiting
- NCT07468110 — Evaluation Of The Relationship Between The Conut Score And Balance And Functional Status In Patients With Chronic Stroke · recruiting
- NCT07468097 — The Impact of Metabolic Status on Pain and Central Sensitization in Women With Lipedema: A Cross-Sectional Observational · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06903390 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Marmara University
- Last refreshed: 10 December 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06903390.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing